14.15
+0.28
+(2.02%)
At close: January 27 at 3:00:03 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Guoqiang Ke | GM & Director | -- | -- | 1982 |
| Mr. Guangzhi Peng | Financial Controller | -- | -- | 1982 |
| Ms. Qun Fei Tan | Deputy GM & Director | -- | -- | 1967 |
| Mr. Run Shi Liang | Secretary of the Board | -- | -- | 1993 |
| Mr. Zhi Hui Chen | Chairman of Supervisory Board & Deputy Director of Human Resources Department - Guangdong Province | -- | -- | 1978 |
DaShenLin Pharmaceutical Group Co., Ltd.
No. 410-1, Longxi Avenue
Liwan District
Guangzhou, 51000
China
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 45,466
Description
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
Corporate Governance
DaShenLin Pharmaceutical Group Co., Ltd.’s ISS Governance QualityScore as of February 1, 2025 is 4. The pillar scores are Audit: 6; Board: 9; Shareholder Rights: 3; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
October 23, 2024 at 12:00 AM UTC
Ex-Dividend Date